REZOLUTE, INC. Current Assets
REZOLUTE, INC. (RZLT) had Current Assets of $110.51 million as of 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-09-24
- 2026-06-30: Assets, Current $110.51M.
- 2026-03-31: Assets, Current $122.05M.
- 2025-12-31: Assets, Current $135.11M.
- 2025-09-30: Assets, Current $154.71M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $110.51M 10-K · filed 2026-09-24 | |
| 2026-03-31 | $122.05M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $135.11M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $154.71M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $171.15M 10-K · filed 2026-09-24 | |
| 2025-03-31 | $88.73M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $98.69M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $110.18M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $128.65M 10-K · filed 2025-09-17 | |
| 2024-03-31 | $82.21M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $96.08M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $102.64M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $104.91M 10-K · filed 2024-09-19 | |
| 2023-03-31 | $105.53M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $147.61M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $155.63M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $152.10M 10-K · filed 2023-09-14 | |
| 2022-03-31 | $64.33M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $78.10M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $38.34M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $41.99M 10-K · filed 2022-09-15 | |
| 2021-03-31 | $32.20M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $38.15M 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $6.89M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $10.52M 10-K · filed 2021-09-15 | |
| 2020-03-31 | $14.17M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $19.97M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $25.92M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $12.14M 10-K · filed 2020-10-13 | |
| 2019-03-31 | $15.36M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $422.28K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $772.99K 10-Q · filed 2018-12-14 | |
| 2018-06-30 | $2.01M 10-K · filed 2019-09-10 | $2.01M 10-K · filed 2018-10-15 |
| 2018-03-31 | $445.93K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.16M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $4.36M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $4.93M 10-K · filed 2018-10-15 | |
| 2017-03-31 | $4.85M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.79M 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $3.73M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.49M 10-K · filed 2017-09-22 | |
| 2016-03-31 | $2.04M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $1.84M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $3.05M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $6.12M 10-K · filed 2016-09-28 | |
| 2015-03-31 | $8.94M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $8.73M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $4.70M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $6.31M 10-K · filed 2015-09-28 | |
| 2014-03-31 | $5.98M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $1.86M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $576.03K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $815.55K 10-K · filed 2014-09-30 | |
| 2013-03-31 | $1.28M 10-Q · filed 2013-05-15 | |
| 2012-06-30 | $1.07M 10-K · filed 2013-09-11 | |
| 2012-03-31 | $6.94K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $565.79K 10-K · filed 2013-09-11 | $15.85K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $23.48K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $37.03K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |